Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201-1549, United States; Psychiatry Residency Training Program, St. Elizabeths Hospital, Washington, DC 20032, United States.
Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201-1549, United States; Division of Child & Adolescent Psychiatry, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201-1549, United States.
J Affect Disord. 2017 Nov;222:126-132. doi: 10.1016/j.jad.2017.06.038. Epub 2017 Jun 22.
We tested the hypothesis that the early improvement in mood after the first hour of bright light treatment compared to control dim-red light would predict the outcome at six weeks of bright light treatment for depressed mood in patients with Seasonal Affective Disorder (SAD). We also analyzed the value of Body Mass Index (BMI) and atypical symptoms of depression at baseline in predicting treatment outcome.
Seventy-eight adult participants were enrolled. The first treatment was controlled crossover, with randomized order, and included one hour of active bright light treatment and one hour of control dim-red light, with one-hour washout. Depression was measured on the Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD version (SIGH-SAD). The predictive association of depression scores changes after the first session. BMI and atypical score balance with treatment outcomes at endpoint were assessed using multivariable linear and logistic regressions.
No significant prediction by changes in depression scores after the first session was found. However, higher atypical balance scores and BMI positively predicted treatment outcome.
Absence of a control intervention for the six-weeks of treatment (only the first session in the laboratory was controlled). Exclusion of patients with comorbid substance abuse, suicidality and bipolar I disorder, and patients on antidepressant medications, reducing the generalizability of the study.
Prediction of outcome by early response to light treatment was not replicated, and the previously reported prediction of baseline atypical balance was confirmed. BMI, a parameter routinely calculated in primary care, was identified as a novel predictor, and calls for replication and then exploration of possible mediating mechanisms.
我们检验了一个假设,即与对照暗光(dim-red light)相比,在接受第一小时强光治疗后情绪的早期改善,将预测季节性情感障碍(Seasonal Affective Disorder,SAD)患者在接受六周强光治疗时的情绪改善。我们还分析了基线时身体质量指数(Body Mass Index,BMI)和抑郁的非典型症状在预测治疗结果中的价值。
共纳入 78 名成年参与者。第一阶段治疗采用随机交叉对照设计,包括一小时主动强光治疗和一小时对照暗光治疗,中间有一小时的洗脱期。使用 SIGH-SAD 对抑郁进行结构化访谈指南(Structured Interview Guide for the Hamilton Rating Scale for Depression-SAD version)评估。采用多变量线性和逻辑回归评估第一阶段后抑郁评分变化与治疗终点结果的预测关联。
未发现第一阶段后抑郁评分变化有显著预测作用。然而,较高的非典型平衡评分和 BMI 与治疗结果呈正相关。
缺乏六周治疗的对照干预(仅实验室的第一阶段是对照)。排除了共患物质滥用、自杀意念和双相 I 障碍的患者,以及正在服用抗抑郁药物的患者,降低了研究的普遍性。
强光治疗早期反应的预测作用未得到复制,并且先前报道的基线非典型平衡的预测作用得到了证实。BMI 是常规在初级保健中计算的参数,被确定为一种新的预测指标,需要进行复制,然后探索可能的中介机制。